CIZ1B Biomarker Blood Test Provider FAQ: Ordering, Use Cases, and Clinical Resources
Short answer
The CIZ1B Biomarker Blood Test for Lung Cancer is designed to support lung cancer assessment in patients with risk factors. It is currently available through licensed healthcare providers in the Dallas-Fort Worth and San Antonio metropolitan areas. Providers can review clinical resources and begin ordering setup through the CIZ1B provider page.
What is CIZ1B?
The CIZ1B test is a biomarker blood test that measures the level of a specific variant of the CIZ1 protein that has been associated with lung cancer. The test analyzes a blood sample and reports whether the CIZ1B biomarker is elevated or non-elevated. The result is intended to provide additional information that may help clinicians assess a patient’s risk of lung cancer. It should be considered alongside medical history, symptoms, risk factors, imaging finding, clinical judgment, and other relevant diagnostic information.
Is the CIZ1B test intended to replace LDCT?
No. CIZ1B is not intended to replace LDCT, imaging, biopsy, specialist evaluation, or comprehensive clinical assessment.
It is designed to complement standard diagnostic approaches by providing additional data for patient assessment.
Who can order the CIZ1B test?
CIZ1B is ordered by licensed healthcare providers.
Patients interested in the CIZ1B Biomarker Blood Test for Lung Cancer should speak with their healthcare provider about whether it may be appropriate.
Where is the CIZ1B test currently available?
The CIZ1B Biomarker Blood Test for Lung Cancer is currently available through licensed healthcare providers in the Dallas-Fort Worth and San Antonio metropolitan areas.
Where might the CIZ1B test provide additional clinical information?
The CIZ1B test may be considered as an adjunctive biomarker test when additional information could support the clinical assessment of lung cancer risk, including:
Patients with established lung cancer risk factors
Patients with pulmonary nodules or other imaging findings requiring further evaluation
Patients with signs or symptoms that warrant assessment for possible lung cancer
Patients with significant occupational or environmental exposures associated with increased lung cancer risk
Patients eligible for LDCT screening, including those who face barriers to completing recommended imaging
Patients undergoing follow-up or surveillance when additional biomarker information may be clinically informative
The CIZ1B test is not intended to replace LDCT, diagnostic imaging, biopsy, or other established standard-of-care diagnostic pathways.
How should CIZ1B results be interpreted?
CIZ1B results should be interpreted by a healthcare provider as part of a comprehensive assessment.
A provider may consider the result alongside:
Patient history
Symptoms
Risk factors
LDCT or other imaging
Specialist evaluation
Additional testing when appropriate
How does provider ordering setup work?
Licensed providers begin with an account setup process. Once account setup and onboarding are complete, the physician can access the provider portal to place CIZ1B orders and receive results.
The general process includes:
Reviewing clinical resources
Submitting provider setup information
Receiving onboarding instructions
Completing onboarding
Placing orders through the provider portal
For a detailed walkthrough of each step, see how healthcare providers can order the CIZ1B Lung Cancer Blood Test.
What happens after setup is submitted?
After setup information is submitted, a representative will follow up with next steps for account setup, onboarding, and provider portal access.
How can providers contact Medical Affairs?
For questions about clinical use of the CIZ1B Biomarker Blood Test for Lung Cancer, licensed healthcare providers can contact the Cizzle Bio Medical Affairs team at clinicians@cizzlebio.com.
Provider next step
Licensed healthcare providers in Dallas-Fort Worth and San Antonio can review clinician resources and ordering setup steps.
Patient note
Patients who are interested in the CIZ1B Biomarker Blood Test should talk with their healthcare provider. The CIZ1B test is ordered through licensed healthcare providers.
Talk with your healthcare provider about whether the CIZ1B test may be appropriate.
Want to learn more first? Visit the CIZ1B Biomarker Blood Test patient page for information you can bring to that conversation.
